Skip to the page

Data / Form D filings / Curative Biotechnology Inc

Curative Biotechnology Inc: Form D filings

Curative Biotechnology Inc, a pharmaceuticals company in Boca Raton, FL, filed 3 Form D notices with the SEC between 2009 and 2023. The latest, on January 18, 2023, reports $146,000 sold of a $919,000 offering to 11 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
1825 NW CORPORATE BLVD, SUITE 110, Boca Raton, FL, 33431
Phone
(561) 907-8990
Industry
Pharmaceuticals
Entity type
Corporation
Incorporated in
Florida
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1400271

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jan 18, 2023New notice$919,000$146,000$773,00011Dec 15, 2022sec.gov
Mar 21, 2022New notice$1,000,000$1,000,0001Mar 4, 2022sec.gov
Oct 13, 2009New notice$500,000$247,500$252,5001Apr 8, 2009sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Michael Richard FishDirector
Lawrence A. ZaslowDirector
Paul Richard MichaelsExecutive Officer, Director
Barry A. GinsbergExecutive Officer, Director
I Richard GarrExecutive Officer
Cary A. SucoffDirector

Other pharmaceuticals companies in Florida that filed recently

Every Form D from the week of Jan 16, 2023 · All recent filings in Florida · All recent Pharmaceuticals filings

Read from SEC EDGAR. Amount sold is what Curative Biotechnology Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.